Tag: Billion

[214 + Pages Research Study] According to a market research study published by Zion Market Research, the demand analysis of Global Methenamine Hippurate Tablets Market size & share revenue was valued at around USD 8.91 billion in 2022 and is estimated to grow about USD 14.74 billion by 2030, at a CAGR of approximately 6.51{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} between 2023 and 2030. The key market players are listed in the report with their sales, revenues and strategies are Almirall, S.A., Mylan N.V., Merck & Co., Inc., Cadila Healthcare Ltd., Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., West-Ward Pharmaceuticals Corp., Abbott Laboratories, Glenmark Pharmaceuticals Ltd., Bausch Health Companies Inc., Procter & Gamble Co., Jubilant Life Sciences Ltd., Lupin Pharmaceuticals, Inc., Cipla Ltd., Amneal Pharmaceuticals LLC., Allergan plc., Novartis AG., Sano

Houston, TX, April 14, 2023 (GLOBE NEWSWIRE) — Zion Market Research has published a new research report titled “Methenamine Hippurate Tablets Market By Application (Healthcare-Associated UTIs And Uncomplicated UTIs), By Type (6 Tablets/ Bottle And 20 Tablets/Bottle), By Distribution Channel (Online Pharmacy, Hospital Pharmacy, And Retail Pharmacy), By End-Users (Homecare, Hospitals, Specialty Clinics, Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.

“According to the latest research study, the demand of global Methenamine Hippurate Tablets Market size & share in terms of revenue was valued at USD 8.91 billion in 2022 and it is expected to surpass around USD 14.74 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 6.51{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} during the forecast period 2023 to 2030.”

What are Methenamine Hippurate Tablets? How big is the Methenamine Hippurate Tablets Industry?

Report Overview:

The global methenamine hippurate tablets market size was worth around USD 8.91 Billion in 2022 and is predicted to grow to around USD 14.74 Billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.51{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} between 2023 and 2030.

Story continues

The methenamine hippurate tablets industry refers to the production and sale of methenamine hippurate tablets which are medicines used for the treatment of urinary tract infections (UTIs) that are caused by bacteria. The infection affects any part of the urinary system in human anatomy including the urethra, kidneys, ureters, and bladder. These UTI-treating tablets are also known as methenamine salts. The fraternity is responsible for the research, production, distribution, and sale of methenamine hippurate tablets. Currently, pharmaceutical companies are one of the leading contributors toward the research and development of medicines During the forecast period, the industry is expected to witness steady growth since in the last 3 years, there have been several breakthrough research activities conducted surrounding further application and development of the medication.

Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs – https://www.zionmarketresearch.com/sample/methenamine-hippurate-tablets-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

• Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.

• The COVID-19 Pandemic Outbreak Impact Analysis is included in the package

• About 214+ Pages Research Report (Including Recent Research)

• Provide detailed chapter-by-chapter guidance on Request

• Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023

• Includes Tables and figures have been updated

• The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis

• Zion Market Research research methodology

(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)

Global Methenamine Hippurate Tablets Market: Growth Factors

The global methenamine hippurate tablets market is projected to grow owing to the increasing female population, which is most prone to contracting UTIs mainly due to the anatomy of the female urinary system. With the growing female population, the chances of more women contracting the disease also increase leading to higher demand in the industry. In addition to this, the infection can also be caused by certain medical conditions like diabetes, kidney stones, and urinary tract abnormality along with some types of birth control agents like diaphragms. These factors are additional contributors to the growth in the target consumer group for the fraternity.

Furthermore, the growing healthcare expenditure observed across the globe is crucial during the forecast period. The healthcare-related expenses are growing due to the increasing demand for healthcare services, the aging population, and the increasing prevalence of chronic diseases. The ongoing research activities directed toward technological advancements also work in the favor of the market size. New technologies and drug delivery systems are crucial aspects of technological growth.

While the growth rate may be steady for the methenamine hippurate tablets industry, it is also expected to encounter certain growth restrictions, especially in terms of rising concerns over the adverse effects of the medicines. Some of the side effects include gastrointestinal disturbances, skin rashes, and allergic reactions. Unless market players can provide medicines with zero unwanted medical impact, the industry may not reach its true potential. Additionally, factors such as limited awareness amongst patients especially in underdeveloped economies, availability of alternative medicines, and patent expiry are other roadblocks against the market growth.

The growing demand for preventive care may provide growth opportunities while the limited availability in developing nations could challenge market growth.

Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/methenamine-hippurate-tablets-market

Report Scope

Methenamine Hippurate Tablets Market: Segmentation Analysis

The global methenamine hippurate tablets market is segmented based on application, type, distribution channel, end-users, and region.

Based on application, the global market segments are healthcare-associated UTIs and uncomplicated UTIs. In 2022, the industry registered the highest growth in the uncomplicated UTIs segment. This is mainly because this type of infection is generally caused by bacteria which can be treated with methenamine hippurate tablets since the bacteria is susceptible to the medicines and can be treated with it alone. However, healthcare-associated UTIs are generally caused by more serious conditions and may be the result of antibiotic-resistant bacteria. In such cases, medical professionals may prescribe the tablet in combination with other antibiotics. In the United States, UTIs are estimated to be responsible for over 8.1 million medical visits every year.

Based on type, the methenamine hippurate tablets industry divisions are 6 tablets/ bottle and 20 tablets/bottle. In 2022, the industry witnessed the highest growth in the 20 tablets/bottle segment since this type of medication is more common in people who may be in need of long-term UTI prophylaxis. Since the number of tablets in this segment is more, the entire treatment plan may be more cost-effective as compared to bottles with a lesser number of tablets. The 6 tablets/bottle segment is more commonly used for patients who require shorter UTI prophylaxis or people who prefer smaller sizes for better portability. The average cost of these tablets with all dosages and packaging sizes combined is around $32 USD per 100 tablets.

Based on distribution channel, the industry divisions are online pharmacy, hospital pharmacy, and retail pharmacy.

The global Methenamine Hippurate Tablets market is segmented as follows:

By Application

By Type

• 6 Tablets/ Bottle

• 20 Tablets/Bottle

By Distribution Channel

• Online Pharmacy

• Hospital Pharmacy

• Retail Pharmacy

By End-Users

• Homecare, Hospitals

• Specialty Clinics

• Others

Browse the full “Methenamine Hippurate Tablets Market By Application (Healthcare-associated UTIs and Uncomplicated UTIs), By Type (6 Tablets/ Bottle and 20 Tablets/Bottle), By Distribution Channel (Online Pharmacy, Hospital Pharmacy, and Retail Pharmacy), By End-Users (Homecare, Hospitals, Specialty Clinics, Others), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030”– Report at https://www.zionmarketresearch.com/report/methenamine-hippurate-tablets-market

Competitive Landscape

Some of the main competitors dominating the global Methenamine Hippurate Tablets market include –

• Almirall

• S.A.

• Mylan N.V.

• Merck & Co. Inc.

• Cadila Healthcare Ltd.

• Pfizer Inc.

• Dr. Reddy’s Laboratories Ltd.

• Teva Pharmaceutical Industries Ltd.

• Sun Pharmaceutical Industries Ltd.

• West-Ward Pharmaceuticals Corp.

• Abbott Laboratories

• Glenmark Pharmaceuticals Ltd.

• Bausch Health Companies Inc.

• Procter & Gamble Co.

• Jubilant Life Sciences Ltd.

• Lupin Pharmaceuticals Inc.

• Cipla Ltd.

• Amneal Pharmaceuticals LLC.

• Allergan plc.

• Novartis AG.

• Sanofi S.A.

 Key Insights from Primary Research:

• According to the analysis shared by our research forecaster, the Methenamine Hippurate Tablets market is likely to expand at a CAGR of around 6.51{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} during the forecast period (2023-2030).

• In terms of revenue, the Methenamine Hippurate Tablets market size was valued at around US$ 8.91 billion in 2022 and is projected to reach US$ 14.74 billion by 2030. The market is projected to grow at a significant rate due to the growing prevalence of UTIs

• Based on distribution channel segmentation, hospital pharmacy was predicted to show maximum market share in the year 2022

• Based on application segmentation, uncomplicated UTIs was the leading application in 2022

• On the basis of region, North America was the leading revenue generator in 2022

Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/methenamine-hippurate-tablets-market

Key questions answered in this report:

• What is the market size and growth rate forecast for Methenamine Hippurate Tablets industry?

• What are the main driving factors propelling the Methenamine Hippurate Tablets Market forward?

• What are the leading companies in the Methenamine Hippurate Tablets Industry?

• What segments does the Methenamine Hippurate Tablets Market cover?

• How can I receive a free copy of the Methenamine Hippurate Tablets Market sample report and company profiles?

Key Offerings:

• Market Size & Forecast by Revenue | 2023−2030

• Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities

• Market Segmentation – A detailed analysis By Application, By Type, By Distribution Channel, By End-Users, And By Region

• Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Request for Customization on this Report as per your requirements – https://www.zionmarketresearch.com/custom/7141

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Regional Analysis:

North America is expected to lead the global methenamine hippurate tablets market owing to the high awareness rate amongst the population about the benefits of using the medication. Furthermore, the presence of key pharmaceutical industry players who are regularly investing in the development of new methenamine hippurate-based products is expected to work in the favor of the regional industry. In Europe, the growth may be driven by the rising demand for preventive care as well as the growing demand for over-the-counter medications. Africa may not register high CAGR mainly due to a lack of awareness and the absence of adequate medical architecture in the region along with a lack of financial assistance leading to many people not having proper access to medical treatments.

By Region

• North America

  • U.S.

  • Canada

  • Rest of North America

• Europe

  • France

  • UK

  • Spain

  • Germany

  • Italy

  • Rest of Europe

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Rest of Asia Pacific

• The Middle East & Africa

• Latin America

  • Brazil

  • Argentina

  • Rest of Latin America

Recent Developments

• In March 2022, Hospital Pharmacy Europe posted a review on methenamine hippurate. In the post, they confirmed that the effectiveness of the methenamine hippurate medication is similar to low-dose prophylactic antibiotics for treating or preventing recurrent urinary tract infections

• In May 2019, The Medicine Products Agencies in Denmark, Sweden, and the United Kingdom approved the pharmaceutical Methenamine hippurate EQL Pharma, tablet 1g for commercial purposes

To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/methenamine-hippurate-tablets-market

FREQUENTLY ASKED QUESTIONS

• What is the methenamine hippurate tablets market?

• Which key factors will influence methenamine hippurate tablets market growth over 2023-2030?

• What will be the value of the methenamine hippurate tablets market during 2023-2030?

• What will be the CAGR value of the methenamine hippurate tablets market during 2023-2030?

• Which region will contribute notably towards the methenamine hippurate tablets market value?

• Which are the major players leveraging the methenamine hippurate tablets market growth?

Browse Other Related Research Reports from Zion Market Research:

Chemotherapy-Induced Myelosuppression Treatment Market: by Indication (Anaemia, Neutropenia and Thrombocytopenia); by Drug Class (Thrombopoietic Agents, Erythropoietin Stimulating Agents, Iron Supplements, Growth Factors and Others); by Route of Administration (Injectable and Oral); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2025: https://www.zionmarketresearch.com/report/chemotherapy-induced-myelosuppression-treatment-market

Dental Fluoride Treatment Market by Product (Toothpaste, Varnish, Gel, Mouth Rinse and Other products) and by Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026: https://www.zionmarketresearch.com/report/dental-fluoride-treatment-market

Bleeding Disorder Treatment Market by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, and Others) and by Drug Class (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytic, Fibrin Sealants, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025: https://www.zionmarketresearch.com/report/bleeding-disorders-treatment-market

Infertility Treatment Market by Product Type (Equipment, Media, and Accessories), by Procedure Type (ART, Insemination, Tube Litigation, and Laparoscopy), by Patient Type (Male and Female), and by End-User (Fertility Clinics, Cryobanks, and Hospitals): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025: https://www.zionmarketresearch.com/report/infertility-treatment-market

Anemia Treatment Market By Anemia (Iron Deficiency, Sickle Cell, Pernicious, Thalassemia, and Hemolytic), By Drug (Bone Marrow Stimulants, Gene Therapy, Iron Chelating Agents, Corticosteroids, Supplements, and Immunotherapy), and By Distribution Channel (Retail Pharmacies, E-Commerce, and Hospital Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025: https://www.zionmarketresearch.com/report/anemia-treatment-market

Uveitis Treatment Market: by Treatment type (corticosteroids, immunosuppressant, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungal, and analgesics), Disease type (anterior uveitis, posterior uveitis, intermediate uveitis and panuveitis), Distribution Channel (hospitals, ophthalmology clinics, ambulatory surgical centers, and others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025: https://www.zionmarketresearch.com/report/uveitis-treatment-market

Phenylketonuria Treatment Market: by Type (Drugs [Kuvan, and Biopten], and Dietary Supplements), by Route of Administration (Oral and Parenteral), and by End User (Hospital Pharmacies, Drug Stores, Online Pharmacies, Pediatric Clinics, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025: https://www.zionmarketresearch.com/report/phenylketonuria-treatment-market

Vaginal Rejuvenation Treatment Market: by Type (Reconstructive Vaginal Rejuvenation [Perineoplasty, and Vaginoplasty], Functional Vaginal Rejuvenation [Clitorial Unhooding, and G-Spot Amplification], and Cosmetic Vaginal Rejuvenation [Labioplasty, Hymenoplasty, and Hoodectomy]): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025: https://www.zionmarketresearch.com/report/vaginal-rejuvenation-treatment-market

Irritable Bowel Syndrome Treatment Market: by Product (Constella/Linzess, Amitiza, Xifaxan, Viberzi, and Others) and Type (IBS-D and IBS-C): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025: https://www.zionmarketresearch.com/report/irritable-bowel-syndrome-treatment-market

Substance Abuse Treatment Market by Abuse Type (Alcohol dependence, Tobacco/Nicotine addiction, Drug abuse and others), and Treatment Type (Alcohol addiction treatment, Tobacco/Nicotine addiction treatment, Drug abuse treatment and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025: https://www.zionmarketresearch.com/report/substance-abuse-treatment-market

About Zion Market Research:

Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/

Follow Us on Twitter: https://twitter.com/zion_research

Follow Us on Facebook: https://www.facebook.com/zionmarketresearch

Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/

Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs

Contact Us:

Rushikesh Dorge

USA: +1 347 690-0211

United Kingdom: +44 2032 894158

Japan: +81 50 5806 9039

India: +91 7768 006 007

Web: https://www.zionmarketresearch.com/

Blog: https://zmrblog.com/

Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?

Email Directly Here with Detail Information: sales@zionmarketresearch.com